Article
Polyvalent mRNA vaccination elicited potent immune response to monkeypox surface antigens
2022-11-29
Abstract excerpt
The soaring global monkeypox cases lead to a surge in demand for monkeypox vaccine, which far exceeds the supply. mRNA vaccine has achieved great success in prevention of coronavirus disease and holds promise against diverse pathogens. In this study, we generate a polyvalent lipid nanoparticle (LNP) mRNA vaccine candidate for monkeypox virus (MPXV) and evaluate its immunogenicity in animal models. This polyvalent...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3f1249e8-cced-5bdd-9e94-a0a55de7e774
- DOI
- 10.1101/2022.11.29.518427
